This trend was associated with clinicopathological stage, lymph node metastasis, and the degree of cell differentiation such that greater tumor differentiation and later clinical stages of CC were linked to lower levels of IGFBP-5 expression. Here, IGFBP5 is linked to metastatic malignant neoplasm in the lymph nodes.